These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 29113279)

  • 1. HMGB1-mediated autophagy confers resistance to gemcitabine in hormone-independent prostate cancer cells.
    Zhang YX; Yuan YQ; Zhang XQ; Huang DL; Wei YY; Yang JG
    Oncol Lett; 2017 Nov; 14(5):6285-6290. PubMed ID: 29113279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maspin mediates the gemcitabine sensitivity of hormone-independent prostate cancer.
    Huang CY; Chang YJ; Luo SD; Uyanga B; Lin FY; Tai CJ; Huang MT
    Tumour Biol; 2016 Mar; 37(3):4075-82. PubMed ID: 26490978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMGB1-mediated autophagy attenuates gemcitabine-induced apoptosis in bladder cancer cells involving JNK and ERK activation.
    Yin H; Yang X; Gu W; Liu Y; Li X; Huang X; Zhu X; Tao Y; Gou X; He W
    Oncotarget; 2017 Sep; 8(42):71642-71656. PubMed ID: 29069735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy.
    Xiong J; Wang D; Wei A; Ke N; Wang Y; Tang J; He S; Hu W; Liu X
    Oncotarget; 2017 Dec; 8(64):107500-107512. PubMed ID: 29296182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.
    Zhang R; Li Y; Wang Z; Chen L; Dong X; Nie X
    Tumour Biol; 2015 Nov; 36(11):8585-92. PubMed ID: 26040768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity.
    Domingo-Domenech J; Oliva C; Rovira A; Codony-Servat J; Bosch M; Filella X; Montagut C; Tapia M; Campás C; Dang L; Rolfe M; Ross JS; Gascon P; Albanell J; Mellado B
    Clin Cancer Res; 2006 Sep; 12(18):5578-86. PubMed ID: 17000695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGB1-mediated autophagy regulates sodium/iodide symporter protein degradation in thyroid cancer cells.
    Chai W; Ye F; Zeng L; Li Y; Yang L
    J Exp Clin Cancer Res; 2019 Jul; 38(1):325. PubMed ID: 31331356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of miR-129-5p increases the sensitivity to Taxol through inhibiting HMGB1-mediated cell autophagy in breast cancer MCF-7 cells.
    Shi Y; Gong W; Lu L; Wang Y; Ren J
    Braz J Med Biol Res; 2019; 52(11):e8657. PubMed ID: 31664305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulated autophagy by endogenous high mobility group box-1 promotes chemoresistance in leukemia cells.
    Yang L; Yu Y; Kang R; Yang M; Xie M; Wang Z; Tang D; Zhao M; Liu L; Zhang H; Cao L
    Leuk Lymphoma; 2012 Feb; 53(2):315-22. PubMed ID: 21864037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folate-targeted nanoparticle delivery of androgen receptor shRNA enhances the sensitivity of hormone-independent prostate cancer to radiotherapy.
    Zhang X; Liu N; Shao Z; Qiu H; Yao H; Ji J; Wang J; Lu W; Chen RC; Zhang L
    Nanomedicine; 2017 May; 13(4):1309-1321. PubMed ID: 28185938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells.
    Liu L; Yang M; Kang R; Wang Z; Zhao Y; Yu Y; Xie M; Yin X; Livesey KM; Lotze MT; Tang D; Cao L
    Leukemia; 2011 Jan; 25(1):23-31. PubMed ID: 20927132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells.
    Amornsupak K; Insawang T; Thuwajit P; O-Charoenrat P; Eccles SA; Thuwajit C
    BMC Cancer; 2014 Dec; 14():955. PubMed ID: 25512109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly-ADP-ribosylation of HMGB1 regulates TNFSF10/TRAIL resistance through autophagy.
    Yang M; Liu L; Xie M; Sun X; Yu Y; Kang R; Yang L; Zhu S; Cao L; Tang D
    Autophagy; 2015; 11(2):214-24. PubMed ID: 25607248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly (ADP-ribosylation) of HMGB1 facilitates its acetylation and promotes HMGB1 translocation-associated chemotherapy-induced autophagy in leukaemia cells.
    Li Y; Xie J; Li X; Fang J
    Oncol Lett; 2020 Jan; 19(1):368-378. PubMed ID: 31897149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-142-3p Overexpression Increases Chemo-Sensitivity of NSCLC by Inhibiting HMGB1-Mediated Autophagy.
    Chen Y; Zhou X; Qiao J; Bao A
    Cell Physiol Biochem; 2017; 41(4):1370-1382. PubMed ID: 28427045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High mobility group box 1-mediated autophagy promotes neuroblastoma cell chemoresistance.
    Wang L; Zhang H; Sun M; Yin Z; Qian J
    Oncol Rep; 2015 Dec; 34(6):2969-76. PubMed ID: 26397184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt/mTOR signaling pathway to prevent Doxorubicin-induced cardiotoxicity.
    Lv X; Zhu Y; Deng Y; Zhang S; Zhang Q; Zhao B; Li G
    Toxicology; 2020 Aug; 441():152508. PubMed ID: 32525084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting the cytoplasmic location of HMGB1 reverses cisplatin resistance in human cervical cancer cells.
    Xia J; Yu X; Song X; Li G; Mao X; Zhang Y
    Mol Med Rep; 2017 Jan; 15(1):488-494. PubMed ID: 27959427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-218 promotes gemcitabine sensitivity in human pancreatic cancer cells by regulating HMGB1 expression.
    Liu Z; Du R; Long J; Guo K; Ge C; Bi S; Xu Y
    Chin J Cancer Res; 2015 Jun; 27(3):267-78. PubMed ID: 26157323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morin Hydrate Reverses Cisplatin Resistance by Impairing PARP1/HMGB1-Dependent Autophagy in Hepatocellular Carcinoma.
    Singh MP; Cho HJ; Kim JT; Baek KE; Lee HG; Kang SC
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31311167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.